The Gut Microbiome: How Trillions of Bacteria Influence Your Health

An Ecosystem Inside the Human Body

The human gut is home to approximately 38 trillion microorganisms — bacteria, archaea, viruses, fungi, and protozoa — collectively called the gut microbiome. This figure, published in a 2016 revision by Sender and colleagues in Cell, closely approximates the number of human cells in the body itself. These microorganisms are not passive passengers. They ferment dietary fiber, synthesize vitamins, regulate immune responses, produce neurotransmitters, and maintain the barrier that separates the gut contents from the bloodstream. Disrupting this ecosystem has measurable consequences — for digestion, immunity, metabolic health, and, increasingly, mental health.

Composition and Diversity

The gut microbiome varies dramatically between individuals. Two people can share fewer than 20% of the same bacterial species. Despite this interpersonal variation, the healthy gut is dominated by two bacterial phyla that together account for 70–90% of the total population:

• Firmicutes: Includes genera such as Lactobacillus, Clostridium, and Faecalibacterium; important for fermentation and butyrate production
• Bacteroidetes: Includes Bacteroides and Prevotella; key fermenters of complex plant polysaccharides
• Actinobacteria: A smaller phylum including Bifidobacterium, prevalent in infants and important for early immune development
• Proteobacteria: Normally a minor component; overgrowth (e.g., E. coli) associated with dysbiosis and disease

Diversity is the most consistent marker of a healthy microbiome. High species diversity is associated with resilience — the ability to recover from disruptions like antibiotic treatment, infection, or dietary changes. Low diversity is associated with obesity, inflammatory bowel disease, metabolic syndrome, and depression. The American Gut Project, one of the largest citizen-science microbiome studies, found that people who ate more than 30 different plant foods per week had significantly more diverse microbiomes than those who ate fewer than 10.

What the Microbiome Does

The Gut-Brain Axis

The gut and brain communicate bidirectionally through the vagus nerve, the enteric nervous system (the gut's own neural network of approximately 500 million neurons), immune signaling, and microbial metabolites. This gut-brain axis has become one of the most active areas of microbiome research.

The gut produces more than 90% of the body's serotonin — not for brain signaling (gut-derived serotonin does not cross the blood-brain barrier) but for regulating gut motility and secretion. Gut bacteria influence serotonin synthesis by producing metabolites that stimulate enterochromaffin cells. Several bacterial species also produce GABA, dopamine precursors, and short-chain fatty acids that act on vagal neurons, transmitting signals to the brain that influence mood, stress responses, and appetite.

Animal studies have produced dramatic findings: germ-free mice (raised with no microbiome) show exaggerated stress responses and anxiety-like behavior that can be normalized by colonizing them with specific bacterial strains. Fecal transplants in rodents have transferred not only metabolic phenotypes (lean-to-obese) but behaviors associated with anxiety and depression. Human clinical trials testing microbiome interventions for mood disorders are underway, with early results showing modest but measurable effects of certain probiotics on depression and anxiety symptoms.

Dysbiosis and Disease

Dysbiosis — a disruption in the composition, diversity, or function of the microbiome — has been associated with an expanding list of conditions, though causality versus correlation remains the central question in much of this research.

• Inflammatory bowel disease (IBD): Crohn's disease and ulcerative colitis are associated with dramatic losses of microbial diversity and overgrowth of pro-inflammatory species; the microbiome is believed to be causally involved
• Obesity and metabolic syndrome: Obese individuals consistently show lower Bacteroidetes and higher Firmicutes ratios, though this pattern reverses with weight loss
• Type 2 diabetes: Specific microbiome signatures (reduced Akkermansia muciniphila, altered SCFA production) consistently appear in T2D patients
• Colorectal cancer: Fusobacterium nucleatum enrichment in tumor tissue; altered bile acid metabolism implicated in tumor promotion
• Clostridioides difficile infection: The clearest causal example — antibiotic-associated loss of commensal bacteria allows C. difficile overgrowth, and fecal microbiota transplantation (FMT) cures over 90% of recurrent cases

Modifying the Microbiome

This article is for informational purposes only. Consult a qualified healthcare professional before making any health decisions.